eflornithine has been researched along with Clerambault Syndrome in 1 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bédat-Millet, AL | 1 |
| Charpentier, S | 1 |
| Monge-Strauss, MF | 1 |
| Woimant, F | 1 |
1 other study available for eflornithine and Clerambault Syndrome
| Article | Year |
|---|---|
[Psychiatric presentation of human African trypanosomiasis: overview of diagnostic pitfalls, interest of difluoromethylornithine treatment and contribution of magnetic resonance imaging].
Topics: Adult; Animals; Brain; Diagnosis, Differential; Eflornithine; Humans; Magnetic Resonance Imaging; Ma | 2000 |